Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling
柯冠銘
柯冠銘
Categories: Journal  /   SCI(Sciences Citation Index)  /  
Year2022
Author
Created date2022-09-24
Author orderFirst author
Corresponding authorYes
Publication year2022
Publication month5
Journal nameVaccines (Basel)
Publication area瑞士聯邦
Volume10
Issue5
Review systemYes
LanguageForeign Language